166 related articles for article (PubMed ID: 9389795)
1. Serum amyloid P component enhances induction of murine amyloidosis.
Togashi S; Lim SK; Kawano H; Ito S; Ishihara T; Okada Y; Nakano S; Kinoshita T; Horie K; Episkopou V; Gottesman ME; Costantini F; Shimada K; Maeda S
Lab Invest; 1997 Nov; 77(5):525-31. PubMed ID: 9389795
[TBL] [Abstract][Full Text] [Related]
2. Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits.
Usui I; Kawano H; Ito S; Hamada Y; Ishihara T; Maeda S
Amyloid; 2001 Jun; 8(2):101-4. PubMed ID: 11409030
[TBL] [Abstract][Full Text] [Related]
3. Formation of experimental murine AA amyloid fibrils in SAP-deficient mice: high resolution ultrastructural study.
Inoue S; Kawano H; Ishihara T; Maeda S; Ohno S
Amyloid; 2005 Sep; 12(3):157-63. PubMed ID: 16194870
[TBL] [Abstract][Full Text] [Related]
4. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
Maeda S
Amyloid; 2003 Aug; 10 Suppl 1():17-20. PubMed ID: 14640037
[TBL] [Abstract][Full Text] [Related]
5. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene.
Botto M; Hawkins PN; Bickerstaff MC; Herbert J; Bygrave AE; McBride A; Hutchinson WL; Tennent GA; Walport MJ; Pepys MB
Nat Med; 1997 Aug; 3(8):855-9. PubMed ID: 9256275
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of amyloid proteins.
Benson MD; Kluve-Beckerman B; Liepnieks JJ; Murrell JR; Hanes D; Uemichi T
Ciba Found Symp; 1996; 199():104-13; discussion 113-8. PubMed ID: 8915606
[TBL] [Abstract][Full Text] [Related]
7. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
[TBL] [Abstract][Full Text] [Related]
8. Role of serum amyloid P component for systemic amyloidosis in transgenic mice carrying human mutant transthyretin gene.
Tashiro F; Yi S; Wakasugi S; Maeda S; Shimada K; Yamamura K
Gerontology; 1991; 37 Suppl 1():56-62. PubMed ID: 1937069
[TBL] [Abstract][Full Text] [Related]
9. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
[TBL] [Abstract][Full Text] [Related]
10. Histological study of experimental murine AA amyloidosis.
Kuroiwa M; Aoki K; Izumiyama N
J Electron Microsc (Tokyo); 2003; 52(4):407-13. PubMed ID: 14599103
[TBL] [Abstract][Full Text] [Related]
11. Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice.
Hoshii Y; Kawano H; Cui D; Takeda T; Gondo T; Takahashi M; Kogishi K; Higuchi K; Ishihara T
Am J Pathol; 1997 Oct; 151(4):911-7. PubMed ID: 9327723
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure.
Yang M; Liu Y; Dai J; Li L; Ding X; Xu Z; Mori M; Miyahara H; Sawashita J; Higuchi K
Sci Rep; 2018 Apr; 8(1):5620. PubMed ID: 29618729
[TBL] [Abstract][Full Text] [Related]
13. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.
Baltz ML; Caspi D; Evans DJ; Rowe IF; Hind CR; Pepys MB
Clin Exp Immunol; 1986 Dec; 66(3):691-700. PubMed ID: 3568456
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the major circulating precursors of proteins deposited in secondary amyloidosis by a recombinant mouse interleukin-1 receptor antagonist.
Grehan S; Herbert J; Whitehead AS
Eur J Immunol; 1997 Oct; 27(10):2593-9. PubMed ID: 9368615
[TBL] [Abstract][Full Text] [Related]
15. Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice.
Kindy MS; Rader DJ
Am J Pathol; 1998 May; 152(5):1387-95. PubMed ID: 9588907
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.
Tennent GA; Lovat LB; Pepys MB
Proc Natl Acad Sci U S A; 1995 May; 92(10):4299-303. PubMed ID: 7753801
[TBL] [Abstract][Full Text] [Related]
17. Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy.
Murakami T; Yi S; Maeda S; Tashiro F; Yamamura K; Takahashi K; Shimada K; Araki S
Am J Pathol; 1992 Aug; 141(2):451-6. PubMed ID: 1497094
[TBL] [Abstract][Full Text] [Related]
18. Association of apolipoprotein E with murine amyloid A protein amyloid.
Kindy MS; King AR; Perry G; de Beer MC; de Beer FC
Lab Invest; 1995 Oct; 73(4):469-75. PubMed ID: 7474917
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E and apolipoprotein A-1 knock-out mice readily develop amyloid A protein amyloidosis.
Elliott-Bryant R; Cathcart ES
Clin Immunol Immunopathol; 1997 Oct; 85(1):104-8. PubMed ID: 9325076
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
Hazenberg BP; van Rijswijk MH; Piers DA; Lub-de Hooge MN; Vellenga E; Haagsma EB; Hawkins PN; Jager PL
Am J Med; 2006 Apr; 119(4):355.e15-24. PubMed ID: 16564782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
